Cytotoxicity and Antimicrobial Activity of Chromium Picolinate Mediated Zinc Oxide Nanoparticle
Journal of Pharmaceutical Research International,
Aim: To study the chromium picolinate mediated with zinc oxide nanoparticle and its cytotoxicity and antimicrobial activity
Introduction: Chromium can alleviate glucose intolerance and insulin resistance and it is involved in the metabolism of glucose, lipid, protein, and nucleic acid .Chromium picolinate [CrPic], also named as picolinic acid chromium and several studies have proved that CrPic, as the source of Chromium, can alleviate the high level of blood glucose, blood lipid, insulin, and cholesterol in the patients with metabolic syndrome and zinc oxide [ZnO] has also gained momentum due to their unique properties in the process of nanotechnology. Chromium picolinate works together with insulin that produced by the pancreas to metabolize carbohydrates. It's made by combining chromium with picolinic acid. The acid helps the body absorb chromium. Randomized controlled trials have failed to demonstrate a link between chromium supplementation and the prevention or treatment of type 2 diabetes or impaired glucose tolerance. Chromium supplementation of young men and women does not promote muscle accretion, fat loss, or gains in strength. Physically active individuals with concerns about meeting guidelines for nutrient intake should be counseled to select and consume foods with high nutrient densities rather than to rely on nutritional supplements.
Materials and Methods: Chromium picolinate mediated with ZnO nanoparticles were evaluated for its antibacterial activity and cytotoxicity potential using brine shrimp lethality assay.
Results: Chromium picolinate mediated zinc oxide nanoparticles show good results in antimicrobial activity as well as in cytotoxicity.
Conclusion: Chromium picolinate mediated Zn nanoparticles is an efficient antibacterial and a potential cytotoxicity agent.
- Chromium picolinate
- brine shrimp
How to Cite
Vincent JB, Stallings D. Introduction: A history of chromium studies (1955–1995). The Nutritional Biochemistry of Chromium (III). 2007;1–40.
Schwarz K, Mertz W. Chromium (III) and the glucose tolerance factor. Archives of Biochemistry and Biophysics. 1959;85: 292–295.
Anderson RA, Bryden NA, Polansky MM. Dietary chromium intake. Freely chosen diets, institutional diet, and individual foods. Biol Trace Elem Res 1992;32:117–121.
Kozlovsky AS, Moser PB, Reiser S, et al. Effects of diets high in simple sugars on urinary chromium losses. Metabolism 1986;35:515–518.
Sumrall KH, Heather Sumrall K, Vincent JB. Is glucose tolerance factor an artifact produced by acid hydrolysis of low-molecular-weight chromium-binding substance? Polyhedron. 1997;16:4171–4177.
Sreejayan N, Dong F, Kandadi MR, et al. Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice. Obesity. 2008;16:1331–1337.
Toghyani M, Toghyani M, Shivazad M, et al. Chromium supplementation can alleviate the negative effects of heat stress on growth performance, carcass traits, and meat lipid oxidation of broiler chicks without any adverse impacts on blood constituents. Biol Trace Elem Res. 2012; 146:171–180.
Anderson RA. Chromium and parenteral nutrition. Nutrition. 1995;11:83–86.
Rodrigo GJ, Plaza V. Efficacy and safety of a fixed-dose combination of indacaterol and glycopyrronium for the treatment of COPD. Chest. 2014;146:309–317.
Lukaski HC. Chromium as a supplement. Annual Review of Nutrition. 1999;19:279–302.
Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997;46:1786–1791.
Yuan L, Wang Y, Wang J, et al. Additive effect of zinc oxide nanoparticles and isoorientin on apoptosis in human hepatoma cell line. Toxicology Letters. 2014;225:294–304.
Koch U, Fojtik A, Weller H, et al. Photochemistry of semiconductor colloids. Preparation of extremely small ZnO particles, fluorescence phenomena and size quantization effects. Chemical Physics Letters. 1985;122:507–510.
Boleman SL, Boleman SJ, Bidner TD, et al. Effect of chromium picolinate on growth, body composition, and tissue accretion in pigs. Journal of Animal Science. 1995;73: 2033–2042.
Sahin K, Onderci M, Sahin N, et al. Effects of Dietary chromium picolinate and ascorbic acid supplementation on egg production, egg quality and some serum metabolites of laying hens reared under a low ambient temperature (6°C). Archiv für Tierernaehrung. 2002;56:41–49.
zha l, zeng j, sun s, et al. chromium(iii) nanoparticles affect hormone and immune responses in heat-stressed rats. Biol Trace Elem Res. 2009;129:157–169.
Psomas G, Dendrinou-Samara C, Philippakopoulos P, et al. CuII-herbicide complexes: structure and bioactivity. Inorganica Chim Acta. 1998;272:24–32.
Houssain MS, Easmin MS, Islam MS, et al. New coordination complexes of chromium as cytotoxic and antimicrobial agents of Biological Sciences.
Wang ZQ, Cefalu WT. Current concepts about chromium supplementation in type 2 diabetes and insulin resistance. Current Diabetes Reports. 2010;10:145–151.
Lewicki S, Zdanowski R, Krzyżowska M, et al. The role of chromium III in the organism and its possible use in diabetes and obesity treatment. Annals of Agricultural and Environmental Medicine. 2014;21: 331–335.
Vincent JB. Chromium: celebrating 50 years as an essential element? Dalton Transactions. 2010;39:3787.
Abstract View: 385 times
PDF Download: 239 times